Antihistamine pricing

Executive Summary

Aventis' Allegra, Schering-Plough's Clarinex, Pfizer's Zyrtec likely will "be moved to a higher tier of co-payment in terms of...managed care formularies" with out-of-pocket costs "being in the range of $25 to $30" when Schering's Claritin switches OTC, Aventis Investor Relations Director Arvind Sood predicts during Q2 analysts call July 31. However, with a monthly supply of Claritin expected to cost about the same, the likelihood that Allegra customers will switch to Claritin "is going to be minimal," Sood maintains...